-transparent.png){kind=logo}
The pharmacokinetics of methylprednisolone and prednisolone were evaluated in 24 healthy men after oral administration of single and multiple doses for 3 days. For each drug, 6 different administration regimens with doses ranging from 1 to 80-mg of methylprednisolone and 1.25 to 100-mg of prednisolone, and administration intervals ranging from 3 to 24 hours for both were investigated. Plasma was assayed using a normal phase high-performance liquid chromatography (HPLC) method. Methylprednisolone showed linear pharmacokinetics with no apparent dose or time dependency. Prednisolone showed marked dose dependency with higher clearance and volume of distribution for higher doses. This can be explained by its saturable protein binding of plasma, because unbound clearance and unbound volume of distribution were not dose-dependent. After multiple administration, prednisolone showed significant time-dependent pharmacokinetics with increased unbound clearance and increased unbound volume of distribution. Due to the complicated pharmacokinetic properties of prednisolone, it is extremely difficult to determine the dose needed to obtain a desired target concentration. The pharmacokinetics of methylprednisolone are more predictable because methylprednisolone concentrations are proportional to dose, and no determination of plasma protein binding is needed.
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
March 1989,
British journal of clinical pharmacology,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
September 1992,
International journal of clinical pharmacology, therapy, and toxicology,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
January 1983,
European journal of clinical pharmacology,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
January 1984,
International journal of clinical pharmacology, therapy, and toxicology,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
April 1988,
Presse medicale (Paris, France : 1983),
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
October 1988,
British journal of clinical pharmacology,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
April 2009,
American journal of veterinary research,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
January 1984,
European journal of clinical pharmacology,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
January 1992,
Clinical pharmacokinetics,
S Rohatagi, and
J Barth, and
H Möllmann, and
G Hochhaus, and
A Soldner, and
C Möllmann, and
H Derendorf
April 2013,
American journal of veterinary research,
